Advertisement

Topics

Companies Related to "Circumcision Mogen Clamp Plastibell Infections" [Most Relevant Company Matches] [Advanced Search Results] RSS

21:03 EDT 20th June 2018 | BioPortfolio

Here are the most relevant search results for "Circumcision Mogen Clamp Plastibell Infections" found in our extensive corporate database of over 50,000 company records.

Showing "Circumcision Mogen Clamp Plastibell Infections" Companies 1–25 of 274

Relevant

ALA Scientific Instruments Incorporated

We are a leading manufacturer of devices for focal drug application to cells and tissue, bath perfusion, and internal cellular perfusion for electrophysiology, cell biology, and neuroscience research.We also represent a variety of products in these f ields from well-known manufacturers such as HEKA (patch clamp amplifiers, data acquisition/analysis software) , NPI (single & two electrode voltage c...


Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs for serious infections such as drug resistance and gram-negative infections. The company has developed an emerging pipeline of p...

Cavit Sciences

Cavit Sciences, Inc. (“Cavit”) is a biotechnology company engaged in developing treatments of cancer and viral infections. Our strategy is to develop and commercialize intellectual property rights to treat, prevent and inhibit several major diseases including cancers, viral infections and diseases associated with cancers and viral infections. We currently own three patent applicati...


Berzelius Clinical Research Center

Berzelius Clinical Research Center AB (BCRC) is a unique Site Management Organisation specialised in clinical conduct of Phase 0/I/II studies and the ideal partner for Contract Research Organisations (CRO) and pharmaceutical companies. BCRC has a hospital based well-equipped clinical pharmacology unit. Having a fully trained critical care staff enables easy setup of invasive techniques and procedu...

Protez Pharmaceuticals

Protez Pharmaceuticals develops new antibiotics to combat the growing problem of drug resistance, as well as agents that improve the efficacy of current antibiotics.Our focus is difficult-to-treat hospital-based infections. In the United States alone, over eight million people are hospitalized with bacterial infections each year, accounting for greater then 90 million days of therapy. Many of thes...

GangaGen, Inc.

GangaGen, Inc. is a biotechnology company focused on the development of proprietary, bacteriophage-based products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. The Company's bacteriophage, both natural and engineered, can be applied broadly to kill bacteri...

Trius Therapeutics, Inc.

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's first product candidate, torezolid phosphate, is an IV and orally administered second generation oxazolidinone being developed for the treatment of serious gram-positive infections, including those caused by ...

Warner Instrument Corporation

Extensive product line includes voltage and current clamp amplifiers for whole-cell and patch applications, Bessel filters, chambers for imaging and recording systems, perfusion control systems and steppers, solution heating systems, microscope translation tables, microelectrodes and holders, and glass capillary tubing. We also provide a growing selection of tools dedicated towards research using ...

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in their bodies. ENBREL can reduce the amount of TNF in the body to normal levels, helping to treat your d...

Probably Relevant

Zurex Pharma, Inc.

Zurex Pharma, Inc. (www.zurexpharma.com) is a specialty pharma and medical technology company with a novel antimicrobial technology platform. The Company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent Health Care-Associated Infections with a focus on surgical site wounds and catheter-related infectio...

Insmed Incorporated

Insmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. Insmed is focused on the development and commercialization of ARIKACE®, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: CF patients with Pseudomonas aeruginosa lung infections and p...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. Basilea focuses its resources and capabilities on the discovery, development and eventual marketing of innovative medicines. The company is ...

nanoMR Inc.

nanoMR is an early stage life sciences company developing novel diagnostic systems for rapid and sensitive identification of pathogens in whole blood and other samples. nanoMR’s system couples immunochemistry with analytical methods such as PCR or DNA hybridization to identify bacterial and fungal infections at clinically-relevant levels. The company...

Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of ...

Pelias

Founded in October 2005, Pelias combines unique know-how and dedicated development expertise in the field of infectious diseases with advanced projects licensed from Chiron and Intercell. On the basis of a lead program that has successfully completed phase I and phase IIa trials, the Company expects to initiate pivotal studies within just 18 months after incorporation. Pelias programs include prev...

Macrolide Pharmaceuticals

Macrolide Pharmaceuticals focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens. Using novel technology, Macrolide Pharmaceuticals can synthesize a broad range of macrolides, and initial compounds show promising anti-bacterial activity. The compa...

NovaCal Pharmaceuticals, Inc

NovaCal Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of compounds: The Aganocideâ„¢ compounds. They are novel, safe and effective non-antibiotic antimicrobial molecules. Our goals are two-fold: 1) to reduce the threat of hospital-based infections, and 2) to provide better treatments for conditions where current therapies are not effective. The Aganocideâ...

Coridon Pty Ltd

Coridon is a privately held company headquartered in Brisbane Australia. The company was founded in 2000 for the purpose of developing DNA therapies for the prevention and treatment of viral infections such as Herpesvirus and Hepatitis C and therapeutic vaccines for the treatment of cancer.Our mission is to develop new DNA immunotherapies that achieve effective immune responses. These effective im...

GlycoVaxyn

GlycoVaxyn is developing a broad portfolio of novel conjugate vaccines against common severe bacterial infections based on its unique, proprietary in-vivo glycosylation platform. With this platform, the company can develop and produce immunogenic glycoproteins in a simplified biological process that circumvents many of the difficulties involved in current ...

MicuRx Pharmaceuticals, Inc.

MicuRx is discovering and developing novel antibiotics to combat infections due to resistant bacteria. Positioned to capture the benefits of United States research and development expertise together with China's abundant scientific talent and cost-effective discovery, preclinical and development, the company has built a pipeline of drug candidates for the treatment of gram positive, gram negative ...

Akonni Biosystems and Eppendorf North America

Akonni Biosystems was founded in 2003 and has over 20 patents issued with 13 others pending. The company’s core technology is based on work developed at Argonne National Laboratory and the Engelhardt Institute of Molecular Biology and utilizes gel-drop array technologies optimized for medical applications. Supported by a series of government grants and ...

Salisbury

Salisbury is your complete source for personal electrical safety products that comply with ASTM requirements and OSHA regulations. Salisbury is the world leader in the manufacturing of personal protective equipment and live line tools to protect electrical workers from the hazards of their job. Salisbury offers the complete solution with insulating rubber gloves, blankets, line hose, temporary gro...

Inhibitex

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel antibody-based products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. We currently have two product candidates in clinical development and four product candidates in preclinical development. Our product candidates have been developed based u...


More From BioPortfolio on "Circumcision Mogen Clamp Plastibell Infections"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks